Biotechnology
Study Highlights the Life-Saving Potential of Obesity Drugs and Strengthens the Bullish Case for Viking Therapeutics
VKTX’s Innovative Drug Candidates Could Unlock Significant Value for Patients and Investors A recent study has shone new light on...
EXCLUSIVE: Immunocore CEO Bahija Jallal on Breakthroughs in Immunotherapy and Expanding Treatment Horizons
Stoxpo: Immunocore has made strides with KIMMTRAK in treating uveal melanoma. What has contributed to this success? Bahija Jallal: KIMMTRAK...
180 Life Sciences Corp. Enters the iGaming Industry with Blockchain-Enabled Platform
Leveraging blockchain and cryptocurrency technology, 180 Life Sciences aims to revolutionize the online casino market In a strategic move that...
Bright Minds Biosciences Soars 1,400% in Unprecedented Stock Surge
In an unexpected and dramatic move, Bright Minds Biosciences (DRUG) saw its stock skyrocket by an astonishing 1,400% yesterday, despite...
Larimar Therapeutics: Targeting the Root Cause of Friedreich’s Ataxia with Nomlabofusp
Biotech company poised to lead FA treatment with innovative protein replacement therapy Larimar Therapeutics (LRMR) has emerged as a promising...
Perspective Therapeutics Expands Radiopharmaceutical Production with New Facility in New Jersey
State-of-the-art facility supports advanced cancer treatment applications, accelerating product distribution Perspective Therapeutics (CATX), a leading radiopharmaceutical company, has announced the...
CATX Showcases Breakthroughs in Radiopharmaceutical Development at Oppenheimer Summit
Targeted radiopharmaceuticals promising multiple catalysts and clinical advancements heading into 2024 CATX (CATX), a company pioneering targeted radiopharmaceutical therapies, provided...
OnKure Positioned for Success with PI3Kα Inhibitor OKI-219 in Breast Cancer
Targeting H1047R Mutations for Improved Efficacy and Reduced Toxicity in an Expanding Market OnKure Therapeutics (OKUR) is making waves in...
VKTX Set to Showcase Promising Higher-Dose Data for Oral VK2735 at ObesityWeek
Potential Upside in Obesity Treatment as Higher Dose Efficacy Data Expected to Boost Competitive Profile Viking Therapeutics (VKTX) is gearing...
Emerging Therapeutic Developments: TYRA, RVMD, IDYA, and More Poised for Key Data Releases
Major trials signal potential advancements in cancer treatment and rare disease therapies Biotech companies are preparing for significant milestones as...
